Presentation TCT 2013 Therapy Pathways Presenter: Howard Herrmann October 27, 2013 REGISTER for free or LOG IN to view this content Aortic Valve Presentation TCT 2013 Up Next Presentation TCT 2013 SYNERGY and the EVOLVE Clinical Trial Program: Minimizing the Abluminal Polymer Load while Accelerating Bioresorption Presenter: Ian Meredith October 27, 2013 More slides + Presentation TCT 2013 The Emerging Role of High Sensitivity Troponin Assays- Benefits and Caveats Presenter: Colin Barker October 27, 2013 Presentation TCT 2013 Stenting Is the First-line Treatment for SFA Disease! Presenter: J. Michael Bacharach October 27, 2013 We Recommend
Presentation TCT 2013 SYNERGY and the EVOLVE Clinical Trial Program: Minimizing the Abluminal Polymer Load while Accelerating Bioresorption Presenter: Ian Meredith October 27, 2013
Presentation TCT 2013 The Emerging Role of High Sensitivity Troponin Assays- Benefits and Caveats Presenter: Colin Barker October 27, 2013
Presentation TCT 2013 Stenting Is the First-line Treatment for SFA Disease! Presenter: J. Michael Bacharach October 27, 2013